Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-73.53M -71.99M -67.93M -70.63M -58.95M -58.35M -54.37M -55.38M -44.08M -38.59M -39.62M -35.06M -34.93M -30.63M -24.91M -19.08M -16.55M -11.73M
Depreciation & Amortization
1.16M 1.14M 1.11M 1.1M 1.08M 1.07M 794K 855K 1.22M 723K 937K 3.71M 1.16M 69K 68K 48K 14K 17K
Stock-Based Compensation
9.72M 10.01M 9.98M 10.36M 10.01M 9.39M 8.85M 8.76M 7.16M 5.85M 5.04M 4.62M 4.53M 4.17M 3.85M 3.46M 2.59M 1.78M
Other Working Capital
5.36M -6.86M 1.92M 7.31M 9.17M -8.15M 4.16M 4.18M 1.38M -3.09M 5.03M -7.46M 3.79M -2.48M 1.08M -893K -243K -676K
Other Non-Cash Items
9.99M -955K -2.6M -6.2M 2.58M 5.22M -4.29M 8.67M -737K -2.74M -2.54M -852K -523K 3.78M 24.7M 1.2M 941K -343K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 7.76M -7.76M n/a n/a n/a n/a n/a n/a -24.7M n/a n/a n/a
Change in Working Capital
7.83M -4.72M -1.13M 13.39M 2.58M -3.24M 4.94M 6.89M 4.37M -4.76M 6.78M -6.86M 2.78M -1.94M 215K 1.46M 1.43M -1.09M
Operating Cash Flow
-54.54M -66.51M -60.58M -51.98M -42.7M -52.53M -44.07M -37.97M -32.07M -39.52M -29.41M -34.44M -26.46M -28.33M -20.78M -14.11M -12.51M -11.37M
Capital Expenditures
-131K -547K -75K -280K -148K -70K -315K -121K -1.26M -1.1M -1.97M -3.31M -1.14M -441K -433K -1.16M -123K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -10.8K 90.42K 76.4K -60.99K -148.23M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-67.88M n/a -12.72M -19.47M -150.4M -73.01M -50.91M -112.47M -126.4M -59.01M -29.62M -148.23M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
76.92M 69.93M 74.47M 79.93M 65.92M 74.13M 61.72M 22.06M 50M 120M 60M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 1.11M 10.8K -90.42K -76.4K 60.99K 148.23M -148.23K n/a n/a n/a n/a n/a n/a
Investing Cash Flow
8.91M 69.38M 61.67M 60.19M -84.63M 1.04M 10.49M -90.54M -77.66M 59.88M 28.41M -151.54M -1.14M -441K -433K -1.16M -123K n/a
Debt Repayment
47.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 720K 213.47M n/a n/a 356K 1.42M 1M 102K 445K 315K 990K 162.12M 138K n/a 55K n/a -85K
Financial Cash Flow
47.23M 24.97M 26K 624K -256K 214.06M n/a 1M 162.09M 445K 315K 990K 162.12M 138K 38.01M 55K n/a -85K
Net Cash Flow
1.59M 27.84M 1.12M 8.83M -127.58M 162.57M -33.58M -127.51M 52.36M 20.81M -682K -184.99M 134.51M -28.64M 16.8M -15.22M -12.63M -11.45M
Free Cash Flow
-54.67M -67.06M -60.65M -52.26M -42.85M -52.6M -44.38M -38.09M -33.32M -40.62M -31.38M -37.75M -27.6M -28.77M -21.21M -15.27M -12.63M -11.37M